Cell-type-specific alternative polyadenylation as a therapeutic biomarker in lung cancer progression

科研成果: 期刊稿件 › 评论/辩论

1 引用（Scopus）

源语言	英语
文章编号	102030
期刊	Molecular Therapy Nucleic Acids
卷	34
DOI	https://doi.org/10.1016/j.omtn.2023.102030
出版状态	已出版 - 12 12月 2023

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

@article{1ee8473a49e544b69e0674c9d4ba5e01,

title = "Cell-type-specific alternative polyadenylation as a therapeutic biomarker in lung cancer progression",

author = "Kang Li and Min Qiang and Yungang Xu",

year = "2023",

month = dec,

day = "12",

doi = "10.1016/j.omtn.2023.102030",

language = "英语",

volume = "34",

journal = "Molecular Therapy Nucleic Acids",

issn = "2162-2531",

publisher = "Cell Press",

}

TY - JOUR

T1 - Cell-type-specific alternative polyadenylation as a therapeutic biomarker in lung cancer progression

AU - Li, Kang

AU - Qiang, Min

AU - Xu, Yungang

PY - 2023/12/12

Y1 - 2023/12/12

UR - https://www.scopus.com/pages/publications/85171540380

U2 - 10.1016/j.omtn.2023.102030

DO - 10.1016/j.omtn.2023.102030

M3 - 评论/辩论

AN - SCOPUS:85171540380

SN - 2162-2531

VL - 34

JO - Molecular Therapy Nucleic Acids

JF - Molecular Therapy Nucleic Acids

M1 - 102030

ER -